Outcome of dogs with low- and high-grade mast cell tumors treated with electrochemotherapy
Authors:
Open Access
- 21 January 2026
- journal article
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 40 (1)
Abstract
Background: Mast cell tumors (MCTs) in dogs pose therapeutic challenges that vary with histopathological grade. Hypothesis/Objectives: Electrochemotherapy (ECT) alone would result in a clinically meaningful response in nonmetastatic cutaneous MCTs, with efficacy varying by tumor grade. Animals: Twenty-nine client-owned dogs with 39 nonmetastatic cutaneous MCTs were treated at a veterinary oncology referral center. Tumors were classified as low grade (n = 27) or high grade (n = 12) according to the Kiupel system. Methods: This retrospective cohort study evaluated outcomes after ECT as the sole treatment. The primary outcomes were complete remission (CR) rate, median survival time, and disease-free interval. Electrochemotherapy was administered using standardized protocols, with follow-up ranging from 30 to 1600 days. Results: Overall complete remission rate was 79% (95% CI, 63.5-90.7). Complete remission was achieved in 100% of low-grade tumors (27/27; 95% CI, 87.2-100) versus 45% of high-grade tumors (5/12; 95% CI, 18.1-75.4). Median survival time was 1198 days (range 188-1920 days) for low-grade MCTs and 210 days (range 45-765 days) for high-grade MCTs (P = .001). Median disease-free interval was 1080 days (range 188-1920 days) and 455 days (range 45-865 days) for low- and high-grade tumors, respectively. Median tumor volume was 4.8 cm3; low-grade tumors were generally smaller. The average number of treatments was 1.1 for low-grade and 1.6 for high-grade tumors. Conclusions and clinical importance: ECT is an effective local treatment for low-grade MCTs, offering outcomes comparable to surgical management. For high-grade tumors, its benefit is limited to small-volume disease where surgery is not feasible.Keywords
This publication has 47 references indexed in Scilit:
- The goat search algorithmsArtificial Intelligence Review, 2022
- Treating Mast Cell Tumors with Electrochemotherapy2021
- Biological factors of the tumour response to electrochemotherapy: Review of the evidence and a research roadmapEuropean Journal of Surgical Oncology, 2021
- Electrochemotherapy in the treatment of cutaneous malignancy: Outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008–2019)European Journal of Cancer, 2020
- Electrochemotherapy in Veterinary OncologyVeterinary Clinics of North America: Small Animal Practice, 2019
- Diagnosis and Prognosis of Canine Cutaneous Mast Cell TumorsVeterinary Clinics of North America: Small Animal Practice, 2019
- Electroporation in veterinary oncologyThe Veterinary Journal, 2016
- Ki67/KIT double immunohistochemical staining in cutaneous mast cell tumors from Boxer dogsResearch in Veterinary Science, 2015
- Numerical Model of Dog Mast Cell Tumor Treated by ElectrochemotherapyArtificial Organs, 2014
- Principles of treatment for mast cell tumorsClinical Techniques in Small Animal Practice, 2003